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Received 30 Oct 2015; first review completed 16 Nov 2015; accepted in final form 7 Jan 2016ABSTRACT—Objective: Fluid responsiveness is proposed as a physiology-based method to titrate fluid therapy based on
preload dependence. The objectives of this study were to determine if a fluid responsiveness protocol would decrease
progression of organ dysfunction, and a fluid responsiveness protocol would facilitate a more aggressive resuscitation.
Methods: Prospective, 10-center, randomized interventional trial. Inclusion criteria: suspected sepsis and lactate 2.0 to
4.0mmol/L. Exclusion criteria (abbreviated): systolic blood pressure more than 90mmHg, and contraindication to aggres-
sive fluid resuscitation. Intervention: fluid responsiveness protocol using Non-Invasive Cardiac Output Monitor (NICOM) to
assess for fluid responsiveness (>10% increase in stroke volume in response to 5mL/kg fluid bolus) with balance of a liter
given in responsive patients. Control: standard clinical care. Outcomes: primary—change in Sepsis-related Organ Failure
Assessment (SOFA) score at least 1 over 72h; secondary—fluids administered. Trial was initially powered at 600 patients,
but stopped early due to a change in sponsor’s funding priorities. Results: Sixty-four patients were enrolled with 32 in the
treatment arm. There were no significant differences between arms in age, comorbidities, baseline vital signs, or SOFA
scores (P>0.05 for all). Comparing treatment versus Standard of Care—there was no difference in proportion of increase in
SOFA score of at least 1 point (30% vs. 33%) (note bene underpowered, P¼1.0) or mean preprotocol fluids 1,050mL (95%
confidence interval [CI]: 786–1,314) vs. 1,031mL (95% CI: 741–1,325) (P¼0.93); however, treatment patients received
more fluids during the protocol (2,633mL [95% CI: 2,264–3,001] vs. 1,002mL [95% CI: 707–1,298]) (P<0.001).
Conclusions: In this study of a ‘‘preshock’’ population, there was no change in progression of organ dysfunction with
a fluid responsiveness protocol. A noninvasive fluid responsiveness protocol did facilitate delivery of an increased volume of
fluid. Additional properly powered and enrolled outcomes studies are needed.
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132INTRODUCTION
Patients with infection-related conditions, in particular sep-
sis, commonly present to the emergency department (ED) (1,
2). Furthermore, sepsis is often a rapidly progressing syndrome
where deterioration to severe illness may occur during the first
few hours of the disease. Therefore, definitive diagnosis
coupled with timely and appropriately aggressive treatment
is critical to ensure optimal patient outcome.
The fluid responsiveness approach to guiding resuscitation is
an approach where one evaluates preload dependence by
dynamic means (i.e., measuring the stroke volume or cardiac
output response to increased preload) (3–6). This contrasts
with traditional staticmeasures of volume status such as central
venous pressure (CVP). The concept is to augment preload
(volume challenge) until cardiac stroke volume (or cardiac
output) no longer increases, thus signifying that the plateau of
the Frank-Starling curve has been reached. This approach has
FIG. 1. Study procedures. Patients were randomized to invention or
standard of care. The information provided by the NICOM in response to a test
bolus of crystalloid 5mL/kg over approximately 10min (maximum infusion
volume 500mL in a 100 kg or greater person) was used to assess whether the
SHOCK AUGUST 2016 COMMIT TO TREAT ED SEPSIS 133been historically limited by the impractical nature of traditional
cardiac output monitoring techniques (i.e., pulmonary arterial
catheter) in the ED. Novel technologies now enable noninva-
sive assessment of stroke volume and cardiac output, thus
making fluid responsiveness approaches feasible in the ED
setting (7). In this trial, we use the Non-Invasive Cardiac Output
Monitor (NICOM), a noninvasive device that uses bioreactance
(a methodology that measures phase shift of an electrical
current) and estimates hemodynamic parameters such as stroke
volume and cardiac output based on changes in signal during
the cardiac cycle.
Since at the time we conducted the study, early goal-directed
therapy (EGDT) was the accepted therapy for patients with
overt shock, we turned our attention to a group of patients
presenting to the ED with earlier stages of the disease, namely
confirmed infection without evidence of severe hypoperfusion
or shock. This population has been previously described as the
preshock population (8). The ability to identify and intervene in
patients with occult hypoperfusion has the potential to curtail
the progression to septic shock. In this study, we attempted to
define a new fluid responsiveness protocol in a ‘‘preshock’’
population. We set out to test the hypothesis that a fluid
administration protocol guided by noninvasive hemodynamic
assessment of fluid responsiveness would reduce the incidence
of progressive organ dysfunction (defined by the worsening of
Sepsis-related Organ Failure Assessment [SOFA] score) within
72 h of enrollment. The secondary hypothesis was that a fluid
responsiveness protocol guided by noninvasive hemodynamic
monitoring would facilitate a more aggressive resuscitation
(higher volume of crystalloid delivered).subject was ‘‘fluid responsive.’’ A subject was considered ‘‘fluid responsive’’ if
his/her stroke volume increased by at least 10% by the end of or within 5min of
the fluid challenge. Per protocol, patientswhowere ‘‘fluid responsive’’ received
additional crystalloid to complete a 1-L infusion over a 30- to 60-min period.
The intervention protocol stopped after four cycles or the primary outcome
was met (e.g., SOFA score increased due to worsening respiratory status or
new hypotension/vasopressor use), and then patients were returned to
standard care. Of note, patients with a negative fluid responsiveness assess-
ment were reassessed at the next cycle and remained eligible for protocol-
driven fluid administration if a subsequent FR assessment was positive.
All patients had a serum lactate measured at 4 h, and were followed for
72 h. FR indicates fluid responsiveness; NICOM, Non-Invasive Cardiac
Output Monitor; SOFA, Sepsis-related Organ Failure Assessment.MATERIALS AND METHODS
Study design
This was a prospective, multicenter, nonblinded randomized-controlled trial
that enrolled ED patients at 10 participating centers. Patients meeting entry
criteria were randomized (1:1, stratified by site, in permutation blocks of 4 to
‘‘Intervention’’ or ‘‘Standard Care’’ arms). ‘‘Intervention’’ patients were treated
with a stroke volume (SV)-guided fluid administration protocol (see Fig. 1),
whereas ‘‘Standard of Care’’ (SOC) patients received care as dictated by the
clinical team. The intervention consisted of up to four fluid bolus cycles, after
which routine care was resumed. The study was registered on clinical trials.gov
(NCT01484106, registered November 28, 2011), and all patients were enrolled
with a written informed consent overseen study-wide by the Beth Israel
Deaconess Committee on Clinical investigations, with each institution’s human
subjects committees approving the study locally. This study was sponsored by
Cheetah Medical.
Study setting and population
The study recruited ED patients from participating centers who met study
entry criteria. The study inclusion criteriawere as follows: adult patients at least
18 years old with suspected or confirmed infection; at least two of the following
four criteria (systemic inflammatory response syndrome): temperature more
than 388C or less than 368C, heart rate more than 90 beats/min, respiratory rate
more than 20 breaths/min or PaCO2 less than 32mmHg, white blood cell count
more than 12,000 or less than 4,000 per mm3; or more than 10% bandemia;
lactate at least 2.0mmol/L but less than 4.0mmol/L; and enrollment within 4 h
of ED presentation and within 2.5 h of meeting eligibility criteria. The exclusion
criteria were as follows: age less than 18 years; on vasopressor therapy; systolic
blood pressure less than 90mmHg (fluid responsive hypotension was permit-
ted); receipt of more than 3L of crystalloid before randomization; the presence
of any of the following: pulmonary edema, acute coronary syndrome, new onset
cardiac arrhythmia, trauma, acute burn, emergent operative diagnosis, stroke,
end-stage renal disease on renal replacement therapy, known pregnancy, treat-
ment with immunosuppressive therapy for organ transplant, end-stage liverdisease with ascites, active gastrointestinal bleeding, toxic ingestion or drug
overdose, left ventricular assist device, advanced directive of ‘‘Do-Not-Treat’’
or ‘‘Comfort care only.’’
Study protocol
Intervention arm patients received care according to a noninvasive fluid
responsiveness algorithm (Fig. 1) where a Bioreactance-based noninvasive
cardiac output monitor (NICOM, Cheetah Medical Inc, Portland, OR) was
used to measure cardiac stroke volume in response to fluid challenges admin-
istered during the 4-h treatment algorithm (Fig. 1). The information provided by
the NICOM in response to a test bolus of crystalloid 5mL/kg over approxi-
mately 10min (maximum infusion volume 500mL in a 100 kg or greater
person) was used to assess whether the subject was ‘‘fluid responsive.’’ A
subject was considered ‘‘fluid responsive’’ if his/her stroke volume increased by
at least 10% by the end of or within 5min of the fluid challenge. Per protocol,
patients who were ‘‘fluid responsive’’ received additional crystalloid to com-
plete a 1 L infusion over a 30- to 60-min period.
For example, a 70-kg individual would receive a 350-mL test bolus over an
approximately 10-min period. If SV increased by at least 10%, then an
additional 650mL over the following 50min was infused. If the patient was
TABLE 1. Demographics
SOC, n¼32 Treatment, n¼32
Demographics
Age (mean years  SD) 58.819.9 60.612.1
Male sex 15 (47%) 15 (47)%
Race: White 21 (66%) 27 (84%)
Race: Black 11 (34%) 5 (16%)
Weight (mean lbsSD) 18552.5 196.360.3
Health history, n (%)
None 7 (21.9%) 8 (25%)
CHF 3 (9.4%) 3 (9.4%)
CAD 3 (9.4%) 3 (9.1%)
MI 1 (3.1%) 2 (6.3%)
COPD 2 (6.3%) 7 (21.9%)
DM 9 (28.1%) 13 (40.6%)
Hypertension 20 (62.5%) 14 (43.8%)
Liver disease 2 (6.3%) 2 (6.3%)
Stroke/TIA 3 (9.4%) 2 (6.3%)
Vital signs
SBP, mmHg) 134.726.7 12821.6
DBP, mmHg 76.522 69.813.5
Temp, 8F 98.311.5 97.911.1
HR, beats/min 106.520.5 102.717.4
RR, breaths/min 20.65.1 20.95.1
SAO2, % 97.72.3 97.12.5
Labs and severity
Lactate, mmol/L 2.50.4 2.70.4
Creatinine, mmol/L 1.20.6 1.20.6
SOFA score 1.01.6 1.21.5
APACHE II score 94.7 105.7
134 SHOCK VOL. 46, No. 2 HOU ET AL.fluid nonresponsive, the protocol dictated that crystalloid was to be given at a
rate to keep the vein open. At the end of the first cycle of the protocol (generally
1 h), the second cycle was initiated with another 5mL/kg (maximum 500mL)
crystalloid bolus to guide further crystalloid administration during that cycle
depending on the SV response, as detailed above. If a patient was fluid
nonresponsive for two successive challenges, then the protocol was halted.
Patients were examined at the end of each fluid bolus for clinical signs of
fluid overload (e.g., new crackles on lung ascultation, increasing shortness of
breath, decreasing O2 saturation); if such signs developed, fluid resuscitation
was halted. The protocol also allowed physicians to suspend the protocol in the
treatment group to perform additional diagnostic and/or therapeutic procedures.
Once the off-protocol procedure or treatment was completed, the fluid respon-
siveness algorithm resumed at the point where it was suspended. The fluid bolus
sequence was carried out for a minimum of four cycles at hours 0, 1, 2, and 3, at
which point the protocol was considered completed.
The ‘‘SOC’’ group received treatment entirely at the discretion of the
treating team and did not receive any hemodynamic monitoring. Both study
groups had a repeat serum lactate measured at the 4-h mark.
Measurements
We collected pertinent vital signs, demographics, comorbidities, as well as
fluid administration data and details of the protocol implementation. A lactate
level was obtained at 4 h in both groups to assess lactate clearance, and this
result was available to the clinical team. In both groups, the hospital chart was
examined for 72 h following enrollment to assess organ dysfunction on days 1,
2, and 3. If the patient was discharged from the hospital before the 72-h time
point, the patient was called at 72 h to make sure that he/she was not readmitted
to another hospital.
Key outcome measures
Primary outcome: The primary outcomewas a worsening of the SOFA score
over the first 72 h, defined as a change in the SOFA score by greater than 1 point.
Secondary outcomes: Secondary outcomes (defined a priori) were as follows:
volume of fluids administered during the protocol; change in lactate level at 4 h
(a serum lactate was drawn in both groups at 4 h after protocol initiation); ICU
admission; and length of hospital stay. Serious related adverse events were
defined as protocol-related events requiring intervention: intubation, noninva-
sive mechanical ventilation, or diuretic administration.
Data analysis
The primary hypothesis tested was that patients who were randomized to
fluid responsiveness guided fluid management would have less frequent
progression of organ dysfunction. The secondary hypothesis was that patients
in the intervention group would receive more fluid as compared with the SOC
group. Both were assessed using a Fisher exact test, witha set for significance at
0.05. Secondary endpoints that were proportions were assessed using Fisher
exact test; those with continuous endpoints were assessed for normality and
compared using either a Wilcoxon rank-sum test or t test, as appropriate.
Sample size
For purposes of initial sample size calculation, it was assumed that the
proportion of patients in the control group who would progress to meet the
primary endpoint of an increase in SOFA score would be 30%, and we powered
the study to detect an absolute reduction in rate of progression by 10% (33%
relative risk reduction) in the treatment group. On the basis of these two
assumptions, 294 patients were required in each group to provide 80% power to
detect a statistically significant difference (a set at 0.05) in the primary outcome
between groups. Thus, assuming a 2% dropout rate, the study was initially
planned to enroll a total of 600 patients. However, the sponsor terminated the
study early (after 65 patients) because of a change in corporate management and
funding priorities. The data saturation monitoring board had no clinical
concerns before or after stopping the study.Pre-enrollment fluids
Normal saline, mL 972765 945669
Medications, mL 6090 105154
Total, mL 1,032804 1,050742
CAD indicates coronary artery disease; CHF, congestive heart failure;
COPD, chronic obstructive pulmonary disease; DBP, diastolic blood
pressure; DM, diabetes mellitus; HR, heart rate; MI, myocardial
infarction; RR, respiratory rate; SAO2, oxygen saturation; SBP, systolic
blood pressure; SOC, Standard of Care; SOFA, Sepsis-related Organ
Failure Assessment; Temp, temperature; TIA, transient ischemic attack.RESULTS
Characteristics of study subjects
There were a total of 65 patients enrolled in the study before
early study termination by the sponsor. One patient in the
treatment group withdrew due to patient preference and was
withdrawn from the study at the patient request, so 64 patients
were included in the analysis. Overall, 19 (30%) patientsreached the primary outcome of increase in SOFA score of
1 point or more. There was one nonsepsis-related death and one
patient received mechanical ventilation, both in the SOC group.
Main results
Demographics and organ dysfunction—There were no sig-
nificant differences between arms in age, comorbidities, base-
line vital signs, or SOFA scores (Table 1). Please note that the
primary outcome comparison is significantly underpowered,
but we report them nonetheless to add perspective and inform
future investigations. Comparing intervention arm to SOC,
there was no difference in increase in SOFA at least 1 (30%
vs. 33%; P¼ 1.0). The average lactate level was similar at 4 h
(1.6 0.7 vs. 1.6  0.7; P¼ 1.0). There was no difference in
the length of stay or ICU admission rate (Table 2).
Fluid management—In regards to fluid administration, the
volume of fluid received by patients before enrollment
was similar: 1,050mL (95% confidence interval [CI]: 786–
1,314mL) vs. 1,032mL (95% CI: 741–1,325mL), P¼ 0.93
(Table 3). However, during the protocol the intervention group
received more fluids: 2,633mL (95% CI: 2,264–3,001) vs.
1,002mL (95% CI: 707–1,298), P< 0.001 (Fig. 2). The mean
TABLE 2. Follow-up characteristics
Outcome SOC, n¼32 Treatment, n¼32 P
Any SOFA increase 1 point 9 (29%) 10 (31%) 1.0
SOFA organ-specific increase 1
SOFA respiratory 3 (9.4%) 2 (6.3%) 1.0
SOFA cardiac 6 (19%) 7 (22%) 1.0
SOFA coagulation 4 (13%) 3 (9.4%) 1.0
SOFA liver 0 (0.0%) 1 (3.1%) 1.0
SOFA neurologic 2 (6.3%) 0 (0.0%) 0.49
SOFA renal 5 (16%) 1 (3.1%) 0.20
Vasopressor use 0 (0%) 0 (0%) 1.0
Change in lactate level over
4 h (mmol/L), mean (SD)
0.91 (0.69) 1.2 (0.65) 0.20
Mechanical ventilation 1 (3.4%) 0 (0%) 1.0
Death 1 (3.4%) 0 (0%) 1.0
Peak creatinine change
over 72 h, mean (SD)
0.15 (0.56) 0.12 (0.26) 0.78
Hospitalization 26 (81%) 31 (97%) 0.10
Hospital LOS (median) 4 (3–5) 3 (2–5) 0.70
ICU admission 5 (17%) 4 (13%) 1.0
ICU indicates intensive care unit; LOS, length of stay; SOC, Standard of
Care; SOFA, Sepsis-related Organ Failure Assessment.
SHOCK AUGUST 2016 COMMIT TO TREAT ED SEPSIS 135amount of fluid administered from time of protocol completion
(or at 3 h in the control group) to 24 h was higher in the SOC
group (851 vs. 1,727mL), P< 0.01 (Table 3). We also show the
distribution of the fluids administered to the two groups during
the protocol, after the protocol period, and overall during the
first 72 h (Fig. 3). Among the patients who received a volume
responsiveness challenge, they were largely responsive at each
time point (Table 4). Overall, 28 of 33 (85%) patients were fluid
responsive to one of the fluid challenges. The total amount of
fluid given as a function of the number of positive fluid
challenges is shown, with the expected relationship between
number of positive tests and total volume of fluid (Table 5).
Adverse events—In terms of serious adverse events, there
was one patient who received mechanical ventilation as an
inpatient in the SOC group. No patients in either group
developed vasopressor-dependent hypotension. There were
two patients in the treatment group who developed signs
and/or symptoms that may have been due to volume overload,
and subsequently received furosemide and oxygen via nasal
cannula but no other interventions. There was one unrelated
(cancer complications) death in the SOC group.DISCUSSION
Although the COMMIT study was prematurely halted due to
termination of financial support by the sponsor, we submit that
this study serves as an important proof-of-concept for the
potential of fluid responsiveness-guided resuscitation in the
ED. We hope that these data may be used to guide futureTABLE 3. Fluids a
Time period SOC, n¼32, mean (95% CI)
Pre-enrollment 1,032mL (741–1,325)
Protocol 1,002mL (707–1,298)
Protocol end to 24h 1,842mL (1,366–2,319)
Total fluids 3,876mL (3,156–4,479)
CI indicates confidence interval; SOC, Standard of Care.initiatives. Although the fluid responsiveness protocol guided
by noninvasive hemodynamicmonitoring did not demonstrate a
reduction in our a priori primary outcome of organ dysfunction,
this assessment was significantly underpowered. However,
our protocol did facilitate an earlier and more vigorous fluid
resuscitation. In addition, we demonstrate that the majority
(85%) of ‘‘preshock’’ patients were fluid responsive to at least
one volume challenge.
Debate remains about the ideal amount of fluid to give in
patients who present to the ED with sepsis, as well as whether a
‘‘fluid-restrictive’’ or a ‘‘fluid-liberal’’ approach is optimal
as there continues to be a lack of solid evidence to guide
clinicians. However, regardless of whether one takes a ‘‘fluid
restrictive’’ or ‘‘fluid liberal’’ approach, giving a patient
additional fluid when they are no longer fluid responsive is
less likely to be of benefit. A fluid responsiveness approach
may offer a more effective means of implementing early fluid
resuscitation in these patients, and we have demonstrated that
this approach provides a feasible means of fluid titration that
accounts for an individual’s unique physiology. Our findings
support the hypothesis that SV-guided fluid resuscitation in the
‘‘preshock’’ patient will result in more aggressive volume
expansion in the early setting.
Although the notion of using physiologic measurements to
guide resuscitation is certainly commonplace, the ideal measure
for this purpose remains controversial. Themost notablemeasure
beyond heart rate and blood pressure is CVP, a primary com-
ponent of EGDT (9). Although CVP may be useful at extreme
values (low or high), the limitations and pitfalls of using CVP are
well described (10, 11). Although a low CVP is typically
indicative of volume depletion, normal or high values may be
indicative of decreased cardiac compliance rather than adequate
volume repletion or volume overload. CVP should certainly be
interpreted with caution, and the search for alternative indices of
volume status is certainly warranted.
The use of stroke volume and cardiac output as a dynamic
measure to guide fluid resuscitation is reasonably well
accepted. It has gained the most recognition in the ICU and
the perioperative setting, where initial studies have demon-
strated outcomes benefit (6). An advantage of SV-guided fluid
challenge approach is that it measures the ‘‘dynamic’’ response
to a relevant physiologic perturbation, namely preload aug-
mentation via a fluid bolus. Initial studies in the perioperative
setting demonstrated decreased mortality rates with guided
therapy. Although large-scale validation in the perioperative
setting has questioned definitive benefit (12), implementation
remains commonplace and the preponderance of evidence still
suggests benefit. Outcomes data in the ICU setting are
less definitive, but SV-guided fluid resuscitation is certainly
prevalent (4).dministration
Treatment, n¼32, mean (95% CI) P
1,050mL (786–1,314) 0.93
2,633mL (2,264–3,001) <0.001
906mL (540–1,272) <0.001
4,588mL (3,891–5,285) 0.23
FIG. 2. Amount of fluids received in the ED. The mean volume of fluid
received by patients before enrollment was similar: 1,050mL (95% CI: 786–
1,314mL) vs. 1,032 mL (95% CI: 741–1,325mL), P¼0.93. However, during
the protocol the intervention group received more fluids: 2,633mL (95% CI:
2,264–3,001) vs. 1,002mL (95% CI: 707–1,298), P<0.001. ED indicates
emergency department.
136 SHOCK VOL. 46, No. 2 HOU ET AL.In the design and implementation of this investigation, there
are a number of considerations that we made whose discussion
might be valuable in designing future studies. For example, weFIG. 3. Fluid administration histogram. This figure is a histogram of the amo
the (A) protocol period, (B) postprotocol period, and (C) in total.selected a ‘‘preshock’’ population as opposed to an overtly
hypotensive population, based on literature suggesting that
downstream decompensation is not an uncommon event, and
the notion that early intervention might prevent decompensa-
tion (13). Thus, these findings do not necessarily apply to a
population in overt shock. We were surprised to find that no
patient in either group went on to develop vasopressor-depend-
ent hypotension; thus, the studied population was less ill than
anticipated. Second, we chose a change in SOFA score more
than 1 as our primary outcome measure. The most common
change was an increase in the cardiac component of the SOFA
score from 0 to 1, which was transient hypotension that
resolved with fluid therapy, so not very clinically significant.
Third, we also chose to use a fluid challenge approach where
we used a 5-mL/kg bolus; a larger bolus may have made a
difference. The passive leg raise technique may also have been
a better option to administer a fluid challenge (14). In our
subsequent experience we found that the passive leg raise was
easier to implement and more reproducible, and this should be a
consideration in future studies (7). Fourth, we used a practical
approach of finishing out a liter if the patient was fluid
responsive as opposed to a strict mL/kg protocol. Fifth, weunt of fluids received, stratified by treatment or standard of care group during
TABLE 4. Stroke volume and average responsiveness at each assessment
Cycle no. No. of patients assessed Average baseline stroke volume Change in stroke volume to bolus, % No. of fluid responsive, n (%)
1 32 63.6 12.9 15 (47)
2 30 63.9 15.4 19 (63)
3 24 67.4 16.1 15 (63)
4 23 64.2 13.6 11 (48)
TABLE 5. Fluid administration by fluid responsiveness episodes
No. of times fluid responsive N (%) Mean, mL 95% CI, mL Min, mL Max, mL
0 4 (13) 1,803 (695–2,912) 1,300 2,150
1 11 (34) 1,905 (1,488–2,323) 750 2,800
2 8 (25) 2,558 (1,951–3,165) 1,500 3,400
3 3 (9) 3,543 (3,162–3,924) 3,400 3,705
4 6 (19) 4,024 (3,797–4,253) 3,700 4,300
CI indicates confidence interval.
SHOCK AUGUST 2016 COMMIT TO TREAT ED SEPSIS 137selected to use the NICOM to guide the fluid therapy, whereas
other more invasive approaches such as esophageal Doppler,
LIDCO, or PICO monitors may have been acceptable choices
(15). Finally, we limited our protocol to four cycles which was
about 3 h, whereas continuing for a longer period may have
yielded better results.
Future studies may consider adopting some of the altern-
atives listed above, with the obvious additional consideration of
an appropriately powered study. For example, perhaps a passive
leg raised based protocol of patients with overt shock may
demonstrate outcomes benefit. Using patient-oriented out-
comes such as mechanical ventilation or organ dysfunction,
or mortality if feasible, would certainly be informative. Given
the debate about fluid restrictive and fluid liberal approaches,
incorporation of vasopressors earlier in the protocols may be a
logical alternative approach. Although our study was sepsis
based, perhaps a resuscitation protocol for any etiology of
shock may be another way forward.
There are a number of limitations to this study, the most
obvious being its early stoppage. This led to an underpowered
investigation for the primary endpoint; however, findings per-
taining to the secondary hypothesis around fluid resuscitation
are worth reporting. In addition to the lack of power to properly
assess our stated primary outcome, our investigation may also
be underpowered to detect meaningful adverse events. Our
choice of SOFA score is not necessarily a ‘‘patient-oriented
outcome’’ and may have been overly sensitive. Our outcomes in
both groups were quite favorable, so although our protocol
facilitated a larger volume of fluid administered within the first
4 h, we cannot truly comment on the ultimate impact on patient
survival. Finally, this was largely an efficacy study where the
intervention was typically delivered by a study team carefully
monitoring the patients, which may not be generalizable to a
routine clinical care environment.
In this abbreviated study in a ‘‘preshock’’ population, there
was no change in progression of organ dysfunction with a fluid
responsiveness protocol guided by noninvasive hemodynamic
monitoring; however, our study was underpowered to address
the primary endpoint. Importantly, we did find that a non-
invasive fluid challenge-guided approach facilitated moreaggressive fluid resuscitation in the ED. This type of approach
holds promise as a standardized method to titrate fluid resus-
citation to an individual patient’s physiologic response. Future
studies on a larger population of ‘‘preshock’’ patients, as well as
more acutely ill populations, using a similar noninvasive
approach, are warranted to determine if reductions in morbidity
and mortality can be achieved.
ACKNOWLEDGMENTS
The authors thank the clinical teams and study teams at all sites for their
participation and support of this project; Drs Deborah Diercks, Judd Hollander,
and Alan Jones for their participation on the Data Safety Monitoring Board; and also
Amanda Milgram, Dr Yoav Avidor, and Dr Daniel Burkhoff for their work on
this project.
REFERENCES
1. Alberti C, Brun-Buisson C, Burchardi H, Martin C, Goodman S, Artigas A,
Sicignano A, Palazzo M, Moreno R, Boulme R, et al.: Epidemiology of sepsis
and infection in ICU patients from an international multicentre cohort study.
Intensive Care Med 28(2):108–121, 2002.
2. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR:
Epidemiology of severe sepsis in the United States: analysis of incidence,
outcome, and associated costs of care. Crit Care Med 29(7):1303–1310, 2001.
3. Teboul JL, Monnet X: Prediction of volume responsiveness in critically ill
patients with spontaneous breathing activity. Curr Opin Crit Care 14(3):334–
339, 2008.
4. Monnet X, Rienzo M, Osman D, Anguel N, Richard C, Pinsky MR, Teboul JL:
Passive leg raising predicts fluid responsiveness in the critically ill. Crit Care
Med 34(5):1402–1407, 2006.
5. Monnet X, Dres M, Ferre A, Le Teuff G, Jozwiak M, Bleibtreu A, Le DeleyMC,
Chemla D, Richard C, Teboul JL: Prediction of fluid responsiveness by a
continuous non-invasive assessment of arterial pressure in critically ill patients:
comparison with four other dynamic indices. Br J Anaesth 109(3):330–338,
2012.
6. McKendry M, McGloin H, Saberi D, Caudwell L, Brady AR, Singer M:
Randomised controlled trial assessing the impact of a nurse delivered, flow
monitored protocol for optimisation of circulatory status after cardiac surgery.
BMJ 329(7460):258, 2004.
7. Duus N, Shogilev DJ, Skibsted S, Zijlstra HW, Fish E, Oren-Grinberg A, Lior Y,
Novack V, Talmor D, Kirkegaard H, et al.: The reliability and validity of passive
leg raise and fluid bolus to assess fluid responsiveness in spontaneously
breathing emergency department patients. J Crit Care 30(1):217e1–217e5,
2015.
8. Arnold RC, Sherwin R, Shapiro NI, O’Connor JL, Glaspey L, Singh S, Medado
P, Trzeciak S, Jones AE, Emergency Medicine Shock Research Network
Investigators. Multicenter observational study of the development of progressive
organ dysfunction and therapeutic interventions in normotensive sepsis patients
in the emergency department. Acad Emerg Med 20(5):433–440, 2013.
138 SHOCK VOL. 46, No. 2 HOU ET AL.9. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E,
TomlanovichM, Early Goal-Directed Therapy Collaborative Group. Early goal-
directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med
345(19):1368–1377, 2001.
10. Marik PE, Baram M, Vahid B: Does central venous pressure predict fluid
responsiveness? A systematic review of the literature and the tale of seven
mares. Chest 134(1):172–178, 2008.
11. Marik PE, Cavallazzi R: Does the central venous pressure predict fluid
responsiveness? An updated meta-analysis and a plea for some common sense.
Crit Care Med 41(7):1774–1781, 2013.
12. Pearse RM, Harrison DA, MacDonald N, Gillies MA, Blunt M, Ackland G,
Grocott MP, Ahern A, Griggs K, Scott R, et al.: Effect of a perioperative, cardiacoutput-guided hemodynamic therapy algorithm on outcomes following major
gastrointestinal surgery: a randomized clinical trial and systematic review.
JAMA 311(21):2181–2190, 2014.
13. Glickman SW, Cairns CB, Otero RM, Woods CW, Tsalik EL, Langley RJ, van
Velkinburgh JC, Park LP, Glickman LT, Fowler VG Jr, et al.: Disease
progression in hemodynamically stable patients presenting to the emergency
department with sepsis. Acad Emerg Med 17(4):383–390, 2010.
14. Jabot J, Teboul JL, Richard C, Monnet X: Passive leg raising for predicting fluid
responsiveness: importance of the postural change. Intensive Care Med
35(1):85–90, 2009.
15. Marik PE: Noninvasive cardiac output monitors: a state-of the-art review.
J Cardiothorac Vasc Anesth 27(1):121–134, 2013.
